Amarin Corp Plc (AMRN)

[KCSVEN]

It depends what's in the docs released a couple days before, there was nothing negative and no surprises in the docs for Aimmune thus the run-up. Amarin has much larger study and much more data, likely there is a little bit of everything covered, and assuming Amarin has been forthcoming no FDA-Amarin communication surprises and no large focus on MO then run-up a bit could happen.